Premenstrual Dysphoric Disorder: Diagnosis and Therapeutic Strategy
From: Département de psychiatrie et Unité d’endocrinologie gynécologique et de médecine de la reproduction, Département de gynécologie obstétrique, HUG, 1211 Genève 14. francesco.bianchi-demicheli@hcuge.ch
Revue médicale suisse
- Publish Date: Feb 2006
- ISSN: 1660-9379
- Volume: 2
- Issue: 52
- Pages: 393-4, 397-9
- Medium: Print
- Language:
- Citation (JAMA): Bianchi-Demicheli F, et al. Premenstrual Dysphoric Disorder: Diagnosis and Therapeutic Strategy. Feb 2006;2:393-4, 397-9
Abstract
Prementrual dysphoric disorder (PMDD) is considered to be a very severe form of the premenstrual syndrome (PMS) that occurs regularly in the last week of the luteal phase of the cycle and begin to remit after the onset of follicular phase and is absent in the week postmenses. What sets PMDD apart from PMS is its severity and its dominant psychiatric symptoms. PMDD includes depression, anxiety, tension, irritability and moodiness. Moreover, women with PMDD find that it has a very disruptive effect on their everyday lives. Although, many treatments have been used for PMDD over the years, PMDD remains difficult to be cured. Until recently, only few of these treatments were evaluated in carefully designed research studies and even fewer were shown to be effective. Here, we discuss the different therapeutic options for PMDD.
Mesh Headings (Keywords): Female, Humans, Premenstrual Syndrome
Check for Full Text / PubMed Unique Identifier (PMID): 16523546
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.